Ototoxicity Completed Phase 3 Trials for Thiosulfuric acid (DB09499)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00716976Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancySupportive Care
NCT00652132Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver CancerTreatment